DDR2 modulator (Locus Pharmaceuticals)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameDDR2 modulator (Locus Pharmaceuticals)
Drug Alias Namedomain receptor tyrosine kinase 2 (Locus Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDiscoidin domain-containing receptor 2 modulators
TargetsDiscoidin domain-containing receptor 2
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLocus
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLocus
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A